India

FICCI’S online certificate course on Competition Law & IPR

We are pleased to inform our readers that the deadline for registration for the May-June 2017 session of the online certificate course on IPR and competition law conducted by the Federation of Indian Chambers of Commerce and Industry (FICCI) has been extended till May 10, 2017. For further details, please read their post below: [...]

By |2017-09-07T18:25:11+05:30May 3rd, 2017|India, IP Basics, Job Openings|0 Comments

Inter–Ministerial Group formed by government

We have in the past covered government’s removal of restrictions on royalty payments by Indian companies to foreign collaborators in cases of technology transfers, usage of trademarks, brand names etc. and how this decision came to be misused by the foreign parent companies. As a first step towards undoing the abuse of this policy, an inter-ministerial group to [...]

By |2017-09-07T18:28:53+05:30May 2nd, 2017|India, IP Basics|0 Comments

Inventions need not be public for sale to be invalidating

In Helsinn Healthcare S.A. v. Teva Pharmaceuticals USA, Inc., the Federal Circuit panel of Judges Dyk, Mayer and O’Malley determined: “after the AIA, if the existence of the sale is public, the details of the invention need not be publicly disclosed in the terms of sale” for the sale to be invalidating. In so [...]

By |2017-09-07T18:32:00+05:30May 2nd, 2017|India, Innovation|0 Comments

Blockchain Technology Space: 5 Consideration to keep in mind

A Blockchain is a subtype of distributed ledger data structure, in which transaction are grouped into “blocks”. Technologies are developing that implement Blockchains to solve all sort of problems related to transaction, privacy, security, data integrity, double spending, payments, interoperability etc. Blockchain technologies are red-hot investment and development space right now will be for [...]

By |2017-09-07T18:37:53+05:30April 29th, 2017|India, Innovation|0 Comments

CCI Orders investigation against Pharma Major Roche

The Competition Commission of India, based on a positive prima facie determination on contravention of Section 4(2)(c) of the Competition Act, ordered investigation against pharma major Roche with respect to the cancer drug, Trastuzumab. The complaint was filed by Biocon and Mylan Pharmaceuticals. Highlights of order The commission is of considered opinion that the [...]

By |2017-09-07T18:42:50+05:30April 27th, 2017|India, IP Basics|0 Comments

GOP Tech Plan Takes Aim at H1-B Visas, Taxes, and Patent Law

In a speech announcing an "Innovation Agenda" for the new Congress, the senator also touted his ties to President Trump, and said he would act as bridge between the tech industry and the White House—a role that could be critical given the open antagonism that exists between Trump and many corners of Silicon Valley. [...]

By |2017-09-07T18:43:52+05:30April 26th, 2017|India, International|0 Comments
Go to Top